ArticleCureus2025
Rare Lupus Exacerbation Shines Light on Provider Bias in a Patient With Possible Autoimmune Hepatitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 42-year-old woman with a past medical history of alcohol use disorder, decompensated alcoholic cirrhosis, systemic lupus erythematosus (SLE), rheumatoid arthritis, and celiac disease presented to the emergency department (ED) for a four-day history of painful rash with worsening pruritus and acute kidney injury. After admission, dermatology, rheumatology, and nephrology teams were consulted, and a skin and renal biopsy were obtained, with results significant for lupus erythematosus tumidus (LET), lupus nephritis grade III (not active), and IgA nephritis, consistent with a systemic lupus erythematosus exacerbation. Despite the patient's history of autoimmune disease, she had previously never received a biopsy for autoimmune hepatitis (AIH) during her initial diagnosis of cirrhosis. During her admission, an autoimmune hepatitis panel was obtained with results suggestive of autoimmune hepatitis; however, a conclusive diagnosis requires a liver biopsy, which was not obtained inpatient. In patients with a strong history of alcohol use, anchoring on substance use as the sole driver of liver disease may be easy, but this case highlights the importance of keeping a wide differential and considering related illnesses, even in patients with pre-existing diagnoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.